EUVIMEDEUVIMED entdecken
Crossref

Spotlight commentary: Redefining drug evaluation in pregnancy: Integrating PBPK modelling and real‐world data

Nina Alebić iD, Luka Žurić

British Journal of Clinical Pharmacology · 05.11.2026

DOI: 10.1002/bcp.70909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 05.11.2026. Verfasst von Nina Alebić und 1 weiteren Autor:innen. Beteiligte Einrichtung: Family Medicine Practice Ksenija Miljević, MD, Dom zdravlja Zagreb - Centar, Zagreb, Croatia. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

drug labellingmaternal pharmacokineticsmodel‐informed drug developmentpharmacovigilancephysiologically based pharmacokinetic modellingpregnancy

Autor:innen und Institutionen

  • Family Medicine Practice Ksenija Miljević, MD, Dom zdravlja Zagreb - Centar, Zagreb, Croatia.
  • Department of Urology, University Hospital Centre Zagreb, Zagreb, Croatia.

ORCID-Profile: Nina Alebić

Zitieren

APA

Alebić, N., & Žurić, L. (2026). Spotlight commentary: Redefining drug evaluation in pregnancy: Integrating PBPK modelling and real‐world data. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70909

Vancouver

Alebić N, Žurić L. Spotlight commentary: Redefining drug evaluation in pregnancy: Integrating PBPK modelling and real‐world data. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70909

BibTeX
@article{Alebi2026,
  author = {Alebić, Nina and Žurić, Luka},
  title = {Spotlight commentary: Redefining drug evaluation in pregnancy: Integrating PBPK modelling and real‐world data},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70909}
}
Kostenlos starten →